Discontinuation report GD-GABAPENTIN
Report ID | 22063 |
Drug Identification Number | 02285827 |
Brand name | GD-GABAPENTIN |
Common or Proper name | Gabapentin |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 tabs |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-01-06 |
Remaining supply date | 2018-01-06 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-01-14 | French | Compare |
v5 | 2019-01-14 | English | Compare |
v4 | 2017-12-08 | French | Compare |
v3 | 2017-12-08 | English | Compare |
v2 | 2017-09-21 | French | Compare |
v1 | 2017-09-13 | English | Compare |
Showing 1 to 6 of 6